These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7540288)

  • 41. The interaction of unfused polyaromatic heterocycles with DNA: intercalation, groove-binding and bleomycin amplification.
    Wilson WD; Tanious FA; Barton HJ; Wydra RL; Jones RL; Boykin DW; Strekowski L
    Anticancer Drug Des; 1990 Feb; 5(1):31-42. PubMed ID: 1690546
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthetic analogues and biosynthetic intermediates of bleomycin. Metal-binding, dioxygen interaction, and implication for the role of functional groups in bleomycin action mechanism.
    Sugiura Y; Suzuki T; Otsuka M; Kobayashi S; Ohno M; Takita T; Umezawa H
    J Biol Chem; 1983 Jan; 258(2):1328-36. PubMed ID: 6185478
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chelating, DNA-binding and DNA-cleaving properties of a synthetic model for bleomycin.
    Kenani A; Lohez M; Houssin R; Helbecque N; Bernier JL; Lemay P; Hénichart JP
    Anticancer Drug Des; 1987 Aug; 2(1):47-59. PubMed ID: 2452643
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The arginine repressor of Escherichia coli K-12 makes direct contacts to minor and major groove determinants of the operators.
    Wang H; Glansdorff N; Charlier D
    J Mol Biol; 1998 Apr; 277(4):805-24. PubMed ID: 9545374
    [TBL] [Abstract][Full Text] [Related]  

  • 45. X-ray crystallographic analysis of 3-(2'-phenyl-2,4'-bithiazole-4-carboxamido) propyldimethylsulphonium iodide, an analogue of the DNA-binding portion of bleomycin A2.
    Kuroda R; Neidle S; Riordan JM; Sakai TT
    Nucleic Acids Res; 1982 Aug; 10(15):4753-63. PubMed ID: 6182526
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Spectroscopic studies of the interaction of ferrous bleomycin with DNA.
    Kemsley JN; Zaleski KL; Chow MS; Decker A; Shishova EY; Wasinger EC; Hedman B; Hodgson KO; Solomon EI
    J Am Chem Soc; 2003 Sep; 125(36):10810-21. PubMed ID: 12952460
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of bleomycin cleavage sites in strongly bound hairpin DNAs.
    Giroux RA; Hecht SM
    J Am Chem Soc; 2010 Dec; 132(47):16987-96. PubMed ID: 21047076
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CC-1065/duocarmycin and bleomycin A2 hybrid agents: lack of enhancement of DNA alkylation by attachment to noncomplementary DNA binding subunits.
    Boger DL; Han N
    Bioorg Med Chem; 1997 Feb; 5(2):233-43. PubMed ID: 9061188
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The genome-wide sequence specificity of DNA cleavage by bleomycin analogues in human cells.
    Murray V; Chen JK; Yang D; Shen B
    Bioorg Med Chem; 2018 Aug; 26(14):4168-4178. PubMed ID: 30006142
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Functional analogues of bleomycin: DNA cleavage by bleomycin and hemin-intercalators.
    Hashimoto Y; Iijima H; Nozaki Y; Shudo K
    Biochemistry; 1986 Sep; 25(18):5103-10. PubMed ID: 2429694
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Cleavage of a double-stranded DNA target by bleomycin derivatives of oligonucleotides, forming a ternary complex].
    Sergeev DS; Godovikova TS; Zarytova VF
    Bioorg Khim; 1995 Mar; 21(3):188-96. PubMed ID: 7539268
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bleomycin analogues. Phenylthiazole models of the bithiazole moiety of bleomycin A2.
    Riordan JM; Sakai TT
    J Med Chem; 1983 Jun; 26(6):884-91. PubMed ID: 6189997
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The DNA sequence specificity of bleomycin cleavage in a systematically altered DNA sequence.
    Gautam SD; Chen JK; Murray V
    J Biol Inorg Chem; 2017 Aug; 22(6):881-892. PubMed ID: 28509989
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The mitomycin C (MMC)-binding protein from MMC-producing microorganisms protects from the lethal effect of bleomycin: crystallographic analysis to elucidate the binding mode of the antibiotic to the protein.
    Danshiitsoodol N; de Pinho CA; Matoba Y; Kumagai T; Sugiyama M
    J Mol Biol; 2006 Jul; 360(2):398-408. PubMed ID: 16756991
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Deoxyribonucleic acid cleavage specificity of a series of acridine- and acodazole-iron porphyrins as functional bleomycin models.
    Lown JW; Sondhi SM; Ong CW; Skorobogaty A; Kishikawa H; Dabrowiak JC
    Biochemistry; 1986 Sep; 25(18):5111-7. PubMed ID: 2429695
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The presence of two modes of binding to calf thymus DNA by metal-free bleomycin: a low frequency Raman study.
    Rajani C; Kincaid JR; Petering DH
    Biopolymers; 1999; 52(3):129-46. PubMed ID: 11169381
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differences between sites of binding to DNA and strand cleavage for complexes of bleomycin with iron or cobalt.
    McLean MJ; Dar A; Waring MJ
    J Mol Recognit; 1989 Apr; 1(4):184-92. PubMed ID: 2483675
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nucleotide-specific cleavage and minor-groove interaction of DNA with esperamicin antitumor antibiotics.
    Sugiura Y; Uesawa Y; Takahashi Y; Kuwahara J; Golik J; Doyle TW
    Proc Natl Acad Sci U S A; 1989 Oct; 86(20):7672-6. PubMed ID: 2813351
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Specificity of deoxyribonucleic acid cleavage by bleomycin, phleomycin, and tallysomycin.
    Kross J; Henner WD; Hecht SM; Haseltine WA
    Biochemistry; 1982 Aug; 21(18):4310-8. PubMed ID: 6181807
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Models of bleomycin interactions with poly(deoxyadenylylthymidylic acid). Fluorescence and proton nuclear magnetic resonance studies of cationic thiazole amides related to bleomycin A2.
    Sakai TT; Riordan JM; Glickson JD
    Biochemistry; 1982 Feb; 21(4):805-16. PubMed ID: 6176265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.